AcoArt III / Arterio-venous Fistula in China

Status Completed

Clinical Trial Summary

This trial is aimed to evaluate the safety and efficacy of DCB in treating AVF stenosis in chinese population.

Clinical Trial Description

For years, first-line treatment of AVFs stenoses has been percutaneous transluminal angioplasty. However, restenosis and reintervention rates remain incredibly high and occur, according to recent studies, in up to 60% and 70% of patients at 6 and 12 months, respectively. Drug-coated balloons delivering paclitaxel at the angioplasty site have proved their superiority in the treatment of coronary and peripheral arterial stenoses. Paclitaxel reduces neointimal hyperplasia and drug-coated balloons,therefore, it represents an attractive option for AVF stenoses. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03366727
Study type	Interventional
Source	Acotec Scientific Co., Ltd
Contact
Status	Completed
Phase	N/A
Start date	May 1, 2018
Completion date	July 7, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06056206` - The SIR-POBA Shunt Trial	N/A
Completed	`NCT05034939` - FLEX Vessel Prep Prior to Angioplasty in Native Arteriovenous Fistulae (AVF)	N/A
Active, not recruiting	`NCT05545267` - Monitoring of Dialysis Vascular Accesses During Angioplasty Under Echodoppler
Recruiting	`NCT04543539` - IN.PACT™ AV Access Post-Approval Study (PAS002)
Completed	`NCT04070365` - FLEX Arteriovenous Access Registry
Completed	`NCT03213756` - Isometric Preoperative Exercise on Autologous Arteriovenous Fistulas. Randomized Clinical Trial	N/A
Completed	`NCT04312711` - 3D Time-of-Flight Magnetic Resonance Angiography in Hemodialysis Patients With Arteriovenous Fistula	N/A
Completed	`NCT05961852` - COmbiNing Cutting and Drug-Eluting Balloon for Resistant Arteriovenous Fistula sTenOsis (CONCERTO)	Phase 1
Completed	`NCT03041467` - IN.PACT™ AV Access IDE Study	N/A